Formulation Facilities

1. HETERO LABS LTD.

  • Unit – III (Jeedimetla):
    Finished dosage manufacturing facility for regulatory markets – USFDA, WHO, ANVISA, GCC, ISO, MCC, Pharmacy Medicine and Poisons Board-MALAWI, AEMPS & UAE Approved
  • Unit – V (Baddi):
    Finished dosage manufacturing facility for Indian market
  • Unit – II (Baddi):
    Finished dosage manufacturing facility for semi-regulatory & Indian markets
  • Unit – V (Jedcherla):
    Solid & Liquid finished dosage manufacturing facility for semi-regulatory & regulatory markets - US FDA, WHO, PICS/GMP Approved
  • Unit – VI (Jedcherla):
    Dedicated Oncology finished dosage manufacturing facility for semi- regulatory & regulatory markets - USFDA, PPB-Kenya, NDA-Uganda, NoMA –Europe (Norway), Zimbabwe, Namibia, Botswana, Malawi, ANVISA (Brazil) Tanzania, TFDA (Taiwan), Ethiopia, Mexico & Belarus (MOH) Approved

Manufacturing Infrastructure
Formulation Facilities